ALRT Diabetes Solution

About ALR Technologies

ALR Technologies operates at the intersection of human and animal health, providing technology-enabled solutions for chronic disease management. Its core offering is the ALRT Diabetes Solution, an FDA-cleared, HIPAA-compliant remote care management platform that collects data from glucose meters and CGMs, features a patent-pending Predictive A1C algorithm, and includes FDA-cleared insulin dose adjustment tools. The company has expanded into the veterinary market with the GluCurve Pet CGM, which it is preparing to relaunch in Canada, and trades publicly on the OTCQB market under the ticker ALRTF.

Therapeutic Areas

Other Diabetes Management Drugs